Bausch Health Companies Inc. (BHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 4B 8B 12B Q3 '21: 8.5B Q4 '21: 8.4B Q1 '22: 8.3B Q2 '22: 8.2B Q3 '22: 8.1B Q4 '22: 8.1B Q1 '23: 8.2B Q2 '23: 8.3B Q3 '23: 8.5B Q4 '23: 8.8B Q1 '24: 9B Q2 '24: 9.2B Q3 '24: 9.5B Q4 '24: 9.6B Q1 '25: 9.7B Q2 '25: 9.9B Q3 '25: 10B Q4 '25: 10.3B Q1 '26: 10.5B Q2 '26: 10.9B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-700M 0 700M 1.4B 2.1B Q3 '20: -395M Q4 '20: 676M Q1 '21: 207M Q2 '21: -36M Q3 '21: 78M Q4 '21: 450M Q1 '22: 956M Q2 '22: 1.4B Q3 '22: 1.1B Q4 '23: 963M Q1 '24: 1.1B Q2 '24: 1B Q3 '24: 1.4B Q4 '24: 1.5B Q1 '25: 1.5B Q2 '25: 1.6B Q3 '25: 1.9B Q4 '25: 1.8B Q1 '26: 587M Q2 '26: 883M Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-1.5B -1B -500M 0 500M 1B 1.5B Q3 '21: -1.2B Q4 '21: -948M Q1 '22: -407M Q2 '22: 43M Q3 '22: 254M Q4 '22: -225M Q1 '23: -357M Q2 '23: -186M Q3 '23: -963M Q4 '23: -592M Q1 '24: -455M Q2 '24: -471M Q3 '24: -178M Q4 '24: -46M Q1 '25: -40M Q2 '25: 98M Q3 '25: 362M Q4 '25: 157M Q1 '26: -1.2B Q2 '26: -1.1B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-1.4B -700M 0 700M 1.4B 2.1B Q3 '21: 1.8B Q4 '21: 1.4B Q1 '22: 920M Q2 '22: 648M Q3 '22: -1.2B Q4 '22: -728M Q1 '23: -511M Q2 '23: -428M Q3 '23: 1.1B Q4 '23: 1B Q1 '24: 1.1B Q2 '24: 1.3B Q3 '24: 1.4B Q4 '24: 1.6B Q1 '25: 1.6B Q2 '25: 1.5B Q3 '25: 1.5B Q4 '25: 1.4B Q1 '26: 1.4B Q2 '26: 1.8B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-1.8B -1.2B -600M 0 600M 1.2B 1.8B Q3 '21: 1.5B Q4 '21: 1.2B Q1 '22: 671M Q2 '22: 409M Q3 '22: -1.4B Q4 '22: -946M Q1 '23: -730M Q2 '23: -623M Q3 '23: 934M Q4 '23: 817M Q1 '24: 839M Q2 '24: 963M Q3 '24: 1.1B Q4 '24: 1.3B Q1 '25: 1.2B Q2 '25: 1.1B Q3 '25: 1.1B Q4 '25: 1B Q1 '26: 1B Q2 '26: 1.4B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '20: 353.4M Q2 '20: 355.3M Q3 '20: 357.8M Q1 '21: 356.8M Q2 '21: 359.1M Q3 '21: 364M Q1 '22: 360.8M Q2 '22: 362.2M Q3 '22: 363.4M Q1 '23: 363.3M Q2 '23: 367.1M Q3 '23: 365.4M Q1 '24: 366.8M Q2 '24: 370.2M Q3 '24: 368.4M Q1 '25: 369.6M Q2 '25: 373.1M Q3 '25: 375.5M Q1 '26: 372.8M Q2 '26: 378.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '21: -3.28 Q4 '21: -2.64 Q1 '22: -1.12 Q2 '22: 0.14 Q3 '22: 0.72 Q4 '22: -0.62 Q1 '23: -0.98 Q2 '23: -0.51 Q3 '23: -2.64 Q4 '23: -1.61 Q1 '24: -1.23 Q2 '24: -1.27 Q3 '24: -0.47 Q4 '24: -0.13 Q1 '25: -0.12 Q2 '25: 0.25 Q3 '25: 0.96 Q4 '25: 0.42 Q1 '26: -3.24 Q2 '26: -2.96 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.